Clinical Laserthermia Systems AB (publ)

OM:CLS BTU B Stock Report

Market Cap: SEK 81.8m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Clinical Laserthermia Systems Management

Management criteria checks 3/4

Clinical Laserthermia Systems' CEO is Dan Mogren, appointed in Dec 2020, has a tenure of 3.58 years. directly owns 0.075% of the company’s shares, worth SEK61.21K. The average tenure of the management team and the board of directors is 2.5 years and 3.5 years respectively.

Key information

Dan Mogren

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure3.6yrs
CEO ownership0.07%
Management average tenure2.5yrs
Board average tenure3.5yrs

Recent management updates

No updates

Recent updates

No updates

CEO Compensation Analysis

How has Dan Mogren's remuneration changed compared to Clinical Laserthermia Systems's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

-SEK 71m

Dec 31 2023n/an/a

-SEK 80m

Sep 30 2023n/an/a

-SEK 63m

Jun 30 2023n/an/a

-SEK 77m

Mar 31 2023n/an/a

-SEK 78m

Dec 31 2022SEK 1mSEK 1m

-SEK 71m

Sep 30 2022n/an/a

-SEK 81m

Jun 30 2022n/an/a

-SEK 63m

Mar 31 2022n/an/a

-SEK 68m

Dec 31 2021SEK 2mSEK 1m

-SEK 64m

Compensation vs Market: Insufficient data to establish whether Dan's total compensation is reasonable compared to companies of similar size in the Swedish market.

Compensation vs Earnings: Dan's compensation has been consistent with company performance over the past year.

CEO

Dan Mogren (60 yo)

3.6yrs

Tenure

SEK 1,373,158

Compensation

Mr. Dan Johansson Mogren was Acting Chief Executive Officer at Clinical Laserthermia Systems AB (publ) since December 01, 2020 until May 2022 and is Chief Executive Officer May 2022 and served as its Chief...

Leadership Team

NamePositionTenureCompensationOwnership
Dan Mogren
Chief Executive Officer3.6yrsSEK 1.37m0.075%
SEK 61.2k
Lars-Erik Eriksson
Co-Founder & Directorno dataSEK 1.65mno data
Hakan Rosqvist
Interim Chief Financial Officerless than a yearno datano data
Jimmy Johansson
Executive Vice President of Operations1.2yrsno data0.0014%
SEK 1.1k
Cristina Pantaleone
Chief Technical Officer2.5yrsno datano data
Liselotte Nilsson
Vice President of Marketing3.5yrsno data0.0047%
SEK 3.8k
Karin Peterson
Chief Product Officerno datano datano data

2.5yrs

Average Tenure

57yo

Average Age

Experienced Management: CLS BTU B's management team is considered experienced (2.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Lars-Erik Eriksson
Co-Founder & Director18.5yrsSEK 1.65mno data
Stephan Dymling
Director2.5yrsSEK 75.00k0.0078%
SEK 6.4k
Hans von Celsing
Independent Chairman of the Board11.5yrsSEK 250.00k0.0036%
SEK 2.9k
Gunilla Savring
Independent Director4.5yrsSEK 142.50kno data
Rolf Kiessling
Member of Clinical Advisory Board3.1yrsSEK 80.00kno data
Karl-Göran Tranberg
Member of Clinical Advisory Board3.1yrsSEK 80.00k0.078%
SEK 63.7k
Paolo Raffaelli
Independent Director3.5yrsSEK 62.50k0.00072%
SEK 588.9
Marika Crohns
Independent Director & Member of Clinical Advisory Board4.5yrsSEK 142.50k0.0070%
SEK 5.7k
Sandy Brandmeier
Independent Director3.5yrsno data0.013%
SEK 10.5k

3.5yrs

Average Tenure

69yo

Average Age

Experienced Board: CLS BTU B's board of directors are considered experienced (3.5 years average tenure).